News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Praveen Kumar Marimuthu: Pembrolizumab in previously treated patients with Advanced Clear Cell Gynecological Cancer
Praveen Kumar Marimuthu/X
May 1, 2025, 09:14

Praveen Kumar Marimuthu: Pembrolizumab in previously treated patients with Advanced Clear Cell Gynecological Cancer

Praveen Kumar Marimuthu, DM Resident in Medical Oncology at Christian Medical College and Hospital, shared an article by Rebecca Kristeleit, et al. on X:

“Pembrolizumab in previously treated patients with Advanced Clear Cell Gynecological Cancer.

  • 12-wk PFS: 42%.
  • ORR: 25%.
  • Median DOR: 13.1 mo.
  • Median OS: 14.8 mo.”

Praveen Kumar Marimuthu: Pembrolizumab in previously treated patients with Advanced Clear Cell Gynecological Cancer

Pembrolizumab in Patients With Advanced Clear Cell Gynecological Cancer: A Phase 2 Nonrandomized Clinical Trial.

Journal: Jama Network

Authors: Rebecca Kristeleit, Michael-John Devlin, Andrew Clamp, Charlie Gourley, René Roux, Marcia Hall, Rachel Nirsimloo, Valentinos Kounnis, Lesley Sage, Priya Narayanan, C. Simon Herrington, Rupali Arora, Laura Farrelly, Laura Hughes, Nicholas Counsel, Rowan E. Miller, et al.

You can Read the Full Article on Journal of JAMA NETWORK.

Praveen Kumar Marimuthu: Pembrolizumab in previously treated patients with Advanced Clear Cell Gynecological Cancer

More posts featuring Praveen Kumar Marimuthu.

Advanced Clear Cell Gynecological Cancer Andrew Clamp C. Simon Herrington cancer Charlie Gourley Christian Medical College and Hospital clinical trial fight against cancer Global fight against cancer Gynecological Cancer JAMA Network Laura Farrelly Laura Hughes Lesley Sage Marcia Hall MedOnc Michael-John Devlin Nicholas Counsel OncoDaily Oncology pembrolizumab Praveen Kumar Marimuthu Priya Narayanan Rachel Nirsimloo Rebecca Kristeleit René Roux Rowan E. Miller Rupali Arora Valentinos Kounnis
Special Coverage
Insight
Aug 2, 2025, 00:36
Elizabeth Smyth: Review on a Key Emerging Biomarker in Gastric and Gastroesophageal Cancer
Blog
Aug 2, 2025, 00:00
Maryam Lustberg: Discussing PCPs vs Oncologists
Blog
Aug 1, 2025, 19:24
Oliver Bogler: What Reviewers Hate to See
Science
Aug 1, 2025, 19:18
Wolfgang Miesbach: How Far Will AI Reach? Stanford's Virtual Lab's Breakthrough
Blog
Aug 1, 2025, 19:14
The Impact Your Support Makes in the Fight Against Cancer - NFCR
Blog
Aug 1, 2025, 19:10
YARN: An Ambitious, Bold and Promising EU-Funded Initiative - Youth Cancer Europe
Science
Aug 1, 2025, 19:04
Karen Knudsen: Science in Action - Men with Advanced Prostate Cancer Benefit
Positive
Aug 1, 2025, 18:57
Two Behaviour Change Campaigns Are the Finalists at 2025 Effie Awards - Cancer Institute NSW
Career
Aug 1, 2025, 18:52
Brian A. Walker Joins Sylvester Myeloma Institute - Sylvester Comprehensive Cancer Center
Blog
Aug 1, 2025, 18:42
Identifying and Preparing Eligible Patients for Screening with Confidence - ACS NLCRT
Insight
Aug 1, 2025, 18:37
Miguel Bronchud: SEOM Has Published the 2025 Medical Oncology Research Dossier in English
Blog
Aug 1, 2025, 18:32
Sharon Kapambwe: Representing WHO in Uzbekistan